Acetylcysteine
From Anvita Health Wiki
Contents |
Introduction
- Tradenames: Mucomyst, Mucosol, Acetadote.
Indications
- adjunctive therapy in patients with abnormal or viscid mucous secretions:
- acute & chronic bronchopulmonary diseases
- of little or no benefit in COPD (see BRONCUS study)
- complications of surgery & cystic fibrosis
- diagnostic bronchial studies
- antidote for acute acetaminophen toxicity
- prevention of renal damage from IV contrast ( contrast nephropathy) [6]
- useful for patients with serum creatinine below 2.0 mg/dL
- trichotillomania [7]
- may decrease compulsive gambling and cocaine addiction
Contraindications
- Caution:
- if bronchospasm occurs
- administer a bronchodilator
- discontinue acetylcysteine if bronchospasm progresses
- percussion, postural drainage & suction should follow adminstration of inhaled acetylcysteine since increased bronchial secretions may develop
Dosage
- oral 20% solution, 3 mL BID one day prior to & on day of procedure to prevent contrast nephropathy
- acetaminophen toxicity:
- load 140 mg/kg PO or NG, then 70 mg/kg every 4 hours X 17 may be mixed in water or soda
- intravenous: (Acetadote) [5]
- 140 mg/kg infused into a peripheral IV over 1 hour using an in-line 0.2-m millipore filter
- maintainance doses every 4 hours of 70 mg/kg infused into a peripheral IV over 1 hour using an in-line 0.2-m millipore filter
- IV solution made by diluting a 20% solution of acetyl- cysteine to 3% with D5W
- millipore filter may be unneccesary with
- average length of treatment is 48 hours
Adverse-effects
- common (> 10%): nausea/vomiting (foul odor)
- less common (1-10%)
- drowsiness, chills, stomatitis, nausea, irritation, bronchospasm, rhinorrhea, hemoptysis, clamminess
- uncommon (< 1%)
- few adverse effects with IV use
- erythema, itching & redness at IV site
- anaphylaxis
Test-interactions
- may falsely lower serum creatinine [4]
Mechanism-of-action
- mucolytic activity results from splitting of disulfide linkages between mucoproteins resulting in depolymerization & a decrease in mucus viscosity
- acetylcysteine protects the liver in acetaminophen toxicity by maintaining glutathione levels & acting as a direct nucleophile reacting with the electrophilic aromatic metabolite of acetaminophen responsible for its toxicity
- modulates the glutamatergic pathway by increasing extracellular glutamate in the nucleus accumbens
More General Terms
Additional Terms
- acetaminophen (Tylenol, Paracematol, Panadol, Tempra, Datril, APAP)
- acetaminophen poisoning
- Bronchitis Randomized on NAC Cost-Utility Study (BRONCUS)
- contrast nephropathy (contrast-induced nephropathy, CIN)
Internet Database
PubChem: 581
PubChem: 12035
PubChem: 44591
PubChem: 500198
PubChem: 469105
References
- The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- Kaiser Permanente Northern California Regional Drug Formulary, 1998
- Prescriber's Letter 9(5):28 2002
- Prescriber's Letter 11(5):28-29 2004 Detail-Document#: [1] (subscription needed) [2]
- Kelly AM et al, Meta-analysis: Effectiveness of drugs for treating contrast- induced nephropathy. Ann Intern Med 2008, 148:284 PMID: [3]
- Grant JE et al N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: A double-blind, placebo-controlled study. Arch Gen Psychiatry 2009 Jul; 66:756. PMID: [4]
